CMS’ “Potential” NCD List Gets Stakeholder Support, But Questions Remain

The device industry and other Medicare stakeholders are generally supportive of CMS' recent move to publicize topics it is considering for future national coverage determinations, though some worry that the agency will use the process to limit patient access to technologies